In-Depth AGE and ALE Profiling of Human Albumin in Heart Failure: Ex Vivo Studies

Antioxidants (Basel)

14 March Mar 2021 8 months ago
  • Zoanni B, Brioschi M, Agostoni P, Banfi C

Advanced glycation end-products (AGEs) and advanced lipoxidation end-products (ALEs), particularly carboxymethyl-lysine (CML), have been largely proposed as factors involved in the establishment and progression of heart failure (HF). Despite this evidence, the current literature lacks the comprehensive identification and characterization of the plasma AGEs/ALEs involved in HF (untargeted approach). This work provides the first ex vivo high-resolution mass spectrometry (HR-MS) profiling of AGEs/ALEs occurring in human serum albumin (HSA), the most abundant protein in plasma, characterized by several nucleophilic sites and thus representing the main protein substrate for AGE/ALE formation.

Reference

Altomare A, Baron G, Balbinot M, Pedretti A, Zoanni B, Brioschi M, Agostoni P, Carini M, Banfi C, Aldini G. In-Depth AGE and ALE Profiling of Human Albumin in Heart Failure: Ex Vivo Studies. Antioxidants (Basel) 2021 Feb 27;10(3):358. doi: 10.3390/antiox10030358.

Go to PubMed